Abstract:OBJECTIVE:To construct a recombinant adenovirus vector of calcitonin gene-related peptide (CGRP) by AdEasy system and to validate its expression in myocardial cells.METHODS:The full-length of CGRP gene cDNA was acquired by RT-PCR and cloned into pShuttle-CMV. After linearization with Pme I, the recombinant plasmid (pShuttle-CMV-CGRP) was transformed into E.coli BJ5183 by electroporation to construct the recombinant adenovirus plasmid AdEasy-pShuttle-CGRP. The recombinant adenovirus plasmids were transformed into E.coli XL10-Gold cells to be amplified. Then the recombinant plasmid was digested with Pac I and transfected to 293 cells to package recombinant adenovirus particles. PCR technique was used to detect target gene. The recombinant adenovirus particles were purified by CsC1 density gradient. The purified recombinant adenovirus was transfected to neonatal rat cardiomyocytes,and the recombinant adenovirus production was observed by fluorescent microscope. Expression of CGRP in hearts 7 days after intravenous delivery of adenoviral vectors AV-CGRP was determined by radioimmunoassay.RESULT:The RT-PCR products confirmed a full-length cDNA of CGRP gene in PUC(57) by sequencing. The corresponding double endonuclease and PCR analysis certified the successful cloning of the gene into the pShuttle-CMV. The recombinant adenovirus plasmid AdEasy-pShuttle-CGRP was digested by Pac I endonuclease to form the typical DNA segments, whose length was about 3 kb and 30 kb. PCR analysis and fluorescent microscope observation confirmed that the CGRP gene was inserted into the adenovirus vector with very strong power of transfection. The recombinant adenovirus particles infected neonatal rat cardiomyocytes successfully. Radioimmunoassay showed that delivery of AV-CGRP significantly increased the expression of CGRP in mice hearts.CONCLUSION:The recombinant adenovirus vector of CGRP gene has been constructed,and it can infect neonatal rat cardiomyocytes successfully. Somatic delivery of CGRP gene can significantly increase the expression of CGRP in mice hearts. The results may provide a sound foundation for further study on the value of CGRP as the target for gene therapy in both laboratory and clinical trials.

Experimental Study on Establishing Eukaryotic Expression Vector Pcdna3.1(+) TPA and Its Expressing Activity in Human Skin Fibroblists.

Construction and Biological Activities of Human Tpa Eukaryotic Expression Plasmid.

Construction of Eukaryotic Expression Plasmid Containing Tpa Genes and Its Expression in Transfected VSMCs

Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells.

Construction of the Prokaryotic Expression Vector of Human Tissue-Type Plasminogen Activator and Its Preliminary Expression in Escherichia coli

Cloning and Expression of the Cdna Encoding Human Tissue Inhibitor of Metalloproteinase-3 and Its Inhibition on Angiogenesis

Cloning and Expression of Human Fetal Cardiac Troponin T Isoform

Study on the Cloning and Expression of Human Fibrinogen Α,β,γ Gene

Application of Homologous Recombination in Vitro to Construct Pcdna3.1-Ngf and Pcdna3.1-Trka

[Effects of Co-Expression Plasmid of Human Tpa and VEGF165 on the Proliferation of Vascular Cells and Fibrinolysis Activity].

Retroviral Vector-Mediated Transfer and Expression of Human Tissue Plasminogen Activator Cdna in Bovine Brain Endothelial Cells

Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli

Construction of PTIE2-CREG-EGFP-N1 eukaryotic expression plasmid and its expression in mouse artery endothelial cells

Construction and Expression in HUVEC of Eukaryotic Expressed Plasmid Vector Pcmv-(Kozak) TFPI

A study on biological activity of co-expression plasmid of human tissue plasminogen activator and vascular endothelial growth factor 165

Expression of Human Vascular Endothelial Growth Factor in Cultured NIH3T3 Cells

[Construction of Co-Expression Plasmid Containing Tpa and VEGF165 Genes and Its Expression in VSMCs].

Construction of a Recombinant Eukaryotic Vector Expressing Human Tumor Necrosis Factor Alpha

[Study on inhibiting the intimal hyperplasia after rabbit artery injury by local transfection of tissue-type plasminogen activator gene].

[Construction of Eukarocyte Expression Recombinant of Human Thymosin Alpha1 and Its Influnce to Immune Activity of PBLs Transfected with the Recombinant Pbk-T Alpha1]

[Construction of Recombinant Adenovirus Vector of Calcitonin Gene-Related Peptide Gene and Transfection to Neonatal Rat Cardiomyocytes].